Business
Profit forecast upgrade obesity diabetes drug sales rises
Novo Nordisk has raised its forecast for the second time this year, reflecting a rosier outlook for obesity and diabetes drug sales. The move…
Novo Nordisk has raised its forecast for the second time this year, reflecting a rosier outlook for obesity and diabetes drug sales. The move…
Smith & Nephew cut its full-year revenue-growth forecast after weaker demand for hip and knee implants in the United States, citing ongoing weakness in…